621 related articles for article (PubMed ID: 28089846)
1. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders.
Yi B; Jahangir A; Evans AK; Briggs D; Ravina K; Ernest J; Farimani AB; Sun W; Rajadas J; Green M; Feinberg EN; Pande VS; Shamloo M
PLoS One; 2017; 12(7):e0180319. PubMed ID: 28746336
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatments with a 5-HT
Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease.
Evans AK; Ardestani PM; Yi B; Park HH; Lam RK; Shamloo M
Neurobiol Dis; 2020 Dec; 146():105089. PubMed ID: 32971233
[TBL] [Abstract][Full Text] [Related]
5. Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.
Batarseh YS; Bharate SS; Kumar V; Kumar A; Vishwakarma RA; Bharate SB; Kaddoumi A
ACS Chem Neurosci; 2017 Aug; 8(8):1756-1766. PubMed ID: 28471166
[TBL] [Abstract][Full Text] [Related]
6. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
[TBL] [Abstract][Full Text] [Related]
7. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
8. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
9. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism.
Medrano-Jiménez E; Jiménez-Ferrer Carrillo I; Pedraza-Escalona M; Ramírez-Serrano CE; Álvarez-Arellano L; Cortés-Mendoza J; Herrera-Ruiz M; Jiménez-Ferrer E; Zamilpa A; Tortoriello J; Pedraza-Alva G; Pérez-Martínez L
J Neuroinflammation; 2019 Jul; 16(1):143. PubMed ID: 31291963
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice.
Jiang Y; Li K; Li X; Xu L; Yang Z
Chem Biol Interact; 2021 May; 341():109452. PubMed ID: 33785315
[TBL] [Abstract][Full Text] [Related]
11. The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease.
Magistri M; Velmeshev D; Makhmutova M; Patel P; Sartor GC; Volmar CH; Wahlestedt C; Faghihi MA
Curr Alzheimer Res; 2016; 13(9):985-95. PubMed ID: 27117003
[TBL] [Abstract][Full Text] [Related]
12. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
13. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.
MacPherson KP; Sompol P; Kannarkat GT; Chang J; Sniffen L; Wildner ME; Norris CM; Tansey MG
Neurobiol Dis; 2017 Jun; 102():81-95. PubMed ID: 28237313
[TBL] [Abstract][Full Text] [Related]
14. Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of Neuroinflammation Effective in Alzheimer's Disease Models.
Zhou W; Zhong G; Fu S; Xie H; Chi T; Li L; Rao X; Zeng S; Xu D; Wang H; Sheng G; Ji X; Liu X; Ji X; Wu D; Zou L; Tortorella M; Zhang K; Hu W
ACS Chem Neurosci; 2016 Nov; 7(11):1499-1507. PubMed ID: 27504670
[TBL] [Abstract][Full Text] [Related]
15. Immune Suppression of Glia Maturation Factor Reverses Behavioral Impairment, Attenuates Amyloid Plaque Pathology and Neuroinflammation in an Alzheimer's Disease Mouse Model.
Ahmed ME; Selvakumar GP; Thangavel R; Kempuraj D; Raikwar SP; Zaheer S; Iyer S; Zaheer A
J Neuroimmune Pharmacol; 2021 Jun; 16(2):363-375. PubMed ID: 32504312
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
Faridar A; Vasquez M; Thome AD; Yin Z; Xuan H; Wang JH; Wen S; Li X; Thonhoff JR; Zhao W; Zhao H; Beers DR; Wong STC; Masdeu JC; Appel SH
Acta Neuropathol Commun; 2022 Sep; 10(1):144. PubMed ID: 36180898
[TBL] [Abstract][Full Text] [Related]
17. The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.
Braun D; Feinstein DL
Brain Res; 2019 Jan; 1702():29-37. PubMed ID: 29274883
[TBL] [Abstract][Full Text] [Related]
18. Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice.
Gourmaud S; Thomas P; Thomasseau S; Tible M; Abadie C; Paquet C; Hugon J
J Alzheimers Dis; 2018; 63(2):665-674. PubMed ID: 29660941
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
[TBL] [Abstract][Full Text] [Related]
20. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.
Gee MS; Son SH; Jeon SH; Do J; Kim N; Ju YJ; Lee SJ; Chung EK; Inn KS; Kim NJ; Lee JK
Alzheimers Res Ther; 2020 Apr; 12(1):45. PubMed ID: 32317025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]